
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
REVIEW article
Front. Oncol. , 10 June 2021
Sec. Cancer Immunity and Immunotherapy
Volume 11 - 2021 | https://doi.org/10.3389/fonc.2021.673276
This article is part of the Research Topic Innate Immune Cell Therapy of Cancer View all 11 articles
A retraction of this article was approved in:
Retraction: CAR-NK Cell: a new paradigm in tumor immunotherapy
Citation: Marofi F, Al-Awad AS, Sulaiman Rahman H, Markov A, Abdelbasset WK, Ivanovna Enina Y, Mahmoodi M, Hassanzadeh A, Yazdanifar M, Stanley Chartrand M and Jarahian M (2021) CAR-NK Cell: A New Paradigm in Tumor Immunotherapy. Front. Oncol. 11:673276. doi: 10.3389/fonc.2021.673276
Received: 09 March 2021; Accepted: 14 May 2021;
Published: 10 June 2021; Retracted: 01 September 2023.
Edited by:
Rizwan Ronee, Dana–Farber Cancer Institute, United StatesReviewed by:
Evren Alici, Karolinska Institutet (KI), SwedenDisclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.